Delivery Order SPE2DB20D2014-SPE2DB25FB93X

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,050.91, is for the delivery of Terbinafine HCL 250 mg tablets. The contract is a firm-fixed-price delivery order with a performance period ending on May 8, 2025. This order is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,202,277 units of the medication Terbinafine HCL 250 mg tablets, with a ceiling value of $8,713.84. The contract is a firm fixed-price Delivery Order, with an ultimate completion date of May 12, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any subcontractors....
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4,567,861 units of the drug Terbinafine Hydrochloride 250 mg Tablets. The contract has a ceiling value of $18,427.98 and a period of performance through April 10, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,039,746 units of terbinafine hydrochloride 250 mg tablets in 100-count bottles. The contract has a firm fixed price of $16,127.89 and a period of performance through April 28, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,184,407 units of the generic pharmaceutical Terbinafine HCL 250 mg tablets in 90-count bottles. The contract has a ceiling value of $12,962.53 and a period of performance through April 8, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to...
This federal contract award, valued at $5,556.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,175,171 units of the medication terbinafine HCL 250 mg tablets, with a completion date of May 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00. This IDC, designated as SPE2DX,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract, with a ceiling value of $92,164.85, is for the delivery of terbinafine hydrochloride 250 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is the prime...
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide 4,568,056,484 units of Terbinafine HCL 250 mg tablets. The contract has a ceiling value of $21,820.64 and a period of performance through April 29, 2025. This contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite...
This federal contract award, valued at $8,773.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,187,358 units of the prescription medication Terbinafine HCL 250 mg tablets, with a final completion date of May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,239,342 units of the drug Terbinafine HCL 250 mg Tablet, with a ceiling value of $12,921.16. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB93X
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Terbinafine HCL 250 mg tablets, a generic antifungal medication, over a period ending on May 14, 2025. The award has a ceiling value of $27,321.19 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and represents an open competition award to the company, which is a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/12/25, 11:59 AM